In a riveting conversation, Bryan Hubbard, Executive Director of the American Ibogaine Initiative, sheds light on the transformative potential of Ibogaine therapy. He discusses how it disrupts addiction cycles and rewires trauma pathways, providing hope for conditions like depression and PTSD. Hubbard also highlights promising studies, especially among veterans, revealing significant improvements in cognitive function. Despite its unapproved status by the FDA, he advocates for a shift in public policy to embrace this innovative treatment, offering a new path for healing.